NO20081675L - Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika - Google Patents
Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytikaInfo
- Publication number
- NO20081675L NO20081675L NO20081675A NO20081675A NO20081675L NO 20081675 L NO20081675 L NO 20081675L NO 20081675 A NO20081675 A NO 20081675A NO 20081675 A NO20081675 A NO 20081675A NO 20081675 L NO20081675 L NO 20081675L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- benzenesulfonamides
- thiadiazol
- cyclic
- compounds
- Prior art date
Links
- -1 Cyclic N- [1,3,4] -thiadiazol-2-yl-benzenesulfonamides Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 108010015181 PPAR delta Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 229940122054 Peroxisome proliferator-activated receptor delta agonist Drugs 0.000 abstract 1
- 229940080774 Peroxisome proliferator-activated receptor gamma agonist Drugs 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 230000003210 demyelinating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004129 fatty acid metabolism Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05021785 | 2005-10-06 | ||
| PCT/EP2006/009299 WO2007039173A1 (fr) | 2005-10-06 | 2006-09-26 | N-[1,3,4]-thiadiazol-2-yl-benzène sulfonamides cycliques, procédés pour leur préparation et leur utilisation en tant que substances pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081675L true NO20081675L (no) | 2008-04-23 |
Family
ID=45218083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081675A NO20081675L (no) | 2005-10-06 | 2008-04-04 | Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7683181B2 (fr) |
| EP (1) | EP1937659B1 (fr) |
| JP (1) | JP2009510145A (fr) |
| KR (1) | KR20080050472A (fr) |
| CN (1) | CN101282952A (fr) |
| AR (1) | AR056562A1 (fr) |
| AT (1) | ATE487706T1 (fr) |
| AU (1) | AU2006299087A1 (fr) |
| BR (1) | BRPI0616886A2 (fr) |
| CA (1) | CA2624326A1 (fr) |
| DE (1) | DE602006018172D1 (fr) |
| IL (1) | IL190464A0 (fr) |
| MA (1) | MA29812B1 (fr) |
| NO (1) | NO20081675L (fr) |
| NZ (1) | NZ567205A (fr) |
| RU (1) | RU2008113208A (fr) |
| UY (1) | UY29847A1 (fr) |
| WO (1) | WO2007039173A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009043784A1 (fr) * | 2007-10-04 | 2009-04-09 | F. Hoffmann-La Roche Ag | Dérivés de cyclopropyl aryl amides et leurs utilisations |
| MX2010006647A (es) | 2007-12-26 | 2010-08-17 | Sanofi Aventis | Piridil-n-[1,3,4]-tiadiazol-2-il-bencenosulfonamidas ciclicas, procedimientos para su preparacion y su uso como productos farmaceuticos. |
| WO2009129267A2 (fr) | 2008-04-14 | 2009-10-22 | The Board Of Regents Of The University Of Texas System | Inhibiteurs de petites molécules du domaine d'homologie de la pleckstrine, et leurs méthodes d'utilisation |
| EP2575815A4 (fr) * | 2010-06-04 | 2013-12-25 | Albany Molecular Res Inc | Inhibiteurs du transporteur 1 de la glycine, procédés de fabrication associés, et utilisations associées |
| US9340532B2 (en) | 2012-12-14 | 2016-05-17 | Phusis Therapeutics, Inc. | Methods and compositions for inhibiting CNKSR1 |
| WO2016172191A1 (fr) | 2015-04-20 | 2016-10-27 | Phusis Therapeutics, Inc. | Composés, compositions et procédés pour inhiber cnksr1 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1049325A1 (en) * | 2000-04-28 | 2003-05-09 | Sankyo Company, Limited | Ppar (gamma) modulators |
-
2006
- 2006-09-26 KR KR1020087008276A patent/KR20080050472A/ko not_active Withdrawn
- 2006-09-26 EP EP06805858A patent/EP1937659B1/fr active Active
- 2006-09-26 CA CA002624326A patent/CA2624326A1/fr not_active Abandoned
- 2006-09-26 BR BRPI0616886-8A patent/BRPI0616886A2/pt not_active IP Right Cessation
- 2006-09-26 AU AU2006299087A patent/AU2006299087A1/en not_active Abandoned
- 2006-09-26 NZ NZ567205A patent/NZ567205A/en not_active IP Right Cessation
- 2006-09-26 RU RU2008113208/04A patent/RU2008113208A/ru not_active Application Discontinuation
- 2006-09-26 AT AT06805858T patent/ATE487706T1/de not_active IP Right Cessation
- 2006-09-26 JP JP2008533905A patent/JP2009510145A/ja not_active Abandoned
- 2006-09-26 CN CNA2006800370657A patent/CN101282952A/zh active Pending
- 2006-09-26 WO PCT/EP2006/009299 patent/WO2007039173A1/fr not_active Ceased
- 2006-09-26 DE DE602006018172T patent/DE602006018172D1/de active Active
- 2006-10-04 AR ARP060104360A patent/AR056562A1/es unknown
- 2006-10-06 UY UY29847A patent/UY29847A1/es not_active Application Discontinuation
-
2008
- 2008-03-26 IL IL190464A patent/IL190464A0/en unknown
- 2008-03-31 MA MA30790A patent/MA29812B1/fr unknown
- 2008-04-04 US US12/062,753 patent/US7683181B2/en active Active
- 2008-04-04 NO NO20081675A patent/NO20081675L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101282952A (zh) | 2008-10-08 |
| BRPI0616886A2 (pt) | 2011-07-05 |
| RU2008113208A (ru) | 2009-10-10 |
| CA2624326A1 (fr) | 2007-04-12 |
| EP1937659A1 (fr) | 2008-07-02 |
| DE602006018172D1 (de) | 2010-12-23 |
| US7683181B2 (en) | 2010-03-23 |
| IL190464A0 (en) | 2008-11-03 |
| JP2009510145A (ja) | 2009-03-12 |
| EP1937659B1 (fr) | 2010-11-10 |
| WO2007039173A1 (fr) | 2007-04-12 |
| US20080280959A1 (en) | 2008-11-13 |
| NZ567205A (en) | 2010-05-28 |
| MA29812B1 (fr) | 2008-09-01 |
| UY29847A1 (es) | 2007-05-31 |
| AR056562A1 (es) | 2007-10-10 |
| KR20080050472A (ko) | 2008-06-05 |
| AU2006299087A1 (en) | 2007-04-12 |
| ATE487706T1 (de) | 2010-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081367L (no) | Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika | |
| NO20092293L (no) | Sulfonyl-fenyl-2H-[1,2,4]oksodiazol-5-onderivater, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytiske midler | |
| MX2010006647A (es) | Piridil-n-[1,3,4]-tiadiazol-2-il-bencenosulfonamidas ciclicas, procedimientos para su preparacion y su uso como productos farmaceuticos. | |
| NO20081682L (no) | 4-oksy-N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika | |
| NO20081369L (no) | Fenyl- og pyridinyl-1,2,4-oksadiazolonderivater, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika | |
| NO20081681L (no) | N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
| EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
| NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
| NO20081675L (no) | Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| TW200505880A (en) | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals | |
| TW200508210A (en) | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
| NO20064951L (no) | 1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse | |
| MY142431A (en) | Oxadiazolones, processes for their preparation and their use as pharmaceuticals | |
| NO20081676L (no) | Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| TW200621732A (en) | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
| TW200510399A (en) | 1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals | |
| NO20081368L (no) | Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika | |
| TW200505830A (en) | Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
| NO20052172D0 (no) | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter | |
| NO20045353L (no) | Orto-substituerte benzosyrederivater for behandling av insulinresistens | |
| NO20063860L (no) | 7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler | |
| DE502004006253D1 (de) | Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung | |
| TW200730516A (en) | Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals | |
| TW200508229A (en) | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |